MIA
ELV icon

MainStreet Investment Advisors’s Elevance Health ELV Stock Holding History

MainStreet Investment Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,918
Closed -$435K – 254
2020
Q1 		$435K Buy
+1,918
New +$523K 0.05% 169

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

MainStreet Investment Advisors's ELV Position: Q2 2020 in Review

MainStreet Investment Advisors sold out of Elevance Health (ELV) in Q2 2020, closing a stake of 1,918 shares — an estimated $435K sold.

MainStreet Investment Advisors first reported a position in ELV in Q1 2020 and held it in 1 quarter. The position peaked at $435K in Q1 2020. 1,106 funds tracked by Wall St. Rank hold ELV as of Q2 2020.

  • MainStreet Investment Advisors reported no remaining Elevance Health position as of Q2 2020 after selling out during the quarter.
  • MainStreet Investment Advisors sold 1,918 Elevance Health shares in Q2 2020, an estimated $435K.
  • MainStreet Investment Advisors first reported a position in Elevance Health in Q1 2020 and held it in 1 quarter.
  • MainStreet Investment Advisors's Elevance Health position peaked at $435K in Q1 2020.
  • 1,106 funds tracked by Wall St. Rank held Elevance Health as of Q2 2020.

Based on MainStreet Investment Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.